@article{93226,
  author = {Lavania M and Darlong J and Reddy A and Ahuja M and Singh I and Turankar R and Sengupta U},
  title = {Successful treatment of rifampicin resistant case of leprosy by WHO recommended ofloxacin and minocycline regimen},
  abstract = {A 25-year-old male treated for leprosy at the age of 15, with MDT, visited TLM Purulia Hospital in July 2017. He was provisionally diagnosed as a lepromatous relapse with ENL reaction. A biopsy was done to test for drug resistance. Drug resistance testing showed resistance to rifampicin. Second line drug regimen recommended by WHO for rifampicin-resistance was started. Within 6 months of taking medication the clinical signs and symptoms improved rapidly and the BI dropped by 1·66 log within 6 months. This case highlights the need for investigations in cases of relapse and the efficacy of WHO recommended second line drug regimen treatment in rifampicin-resistant leprosy cases.},
  year = {2019},
  journal = {Leprosy review},
  volume = {90},
  pages = {456–459},
  url = {https://leprosyreview.org/article/90/4/19-0059},
  language = {eng},
}